PharmaShots | Incisive News in 3 Shots

Subscribe Now

Influenza A

Seqirus' Audenz Receives the US FDA's Approval as the First Adjuvanted Cell-Based Pandemic Influenza A (H5N1) Vaccine

Seqirus' Audenz Receives the US FDA's Approval as the First Adjuvanted Cell-Based Pandemic Influenza A (H5N1) Vaccine

February 5, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us